Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Cyclospora parasite illnesses have affected 28 NC counties, sickened more than 200 people
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vericel Corporation
(NQ:
VCEL
)
47.07
+0.93 (+2.02%)
Streaming Delayed Price
Updated: 2:51 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vericel Corporation
< Previous
1
2
3
Next >
Expert Ratings For Vericel
August 09, 2024
Via
Benzinga
The Latest Analyst Ratings For Vericel
August 02, 2024
Via
Benzinga
Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
August 02, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts
July 16, 2024
Via
Benzinga
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
The 3 Highest-Rated Medical Stocks You Can Buy Today
June 27, 2024
Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.
Via
InvestorPlace
Critical Insights From Vericel Analyst Ratings: What You Need To Know
May 09, 2024
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Vericel
March 26, 2024
Via
Benzinga
A Closer Look at 4 Analyst Recommendations For Vericel
March 01, 2024
Via
Benzinga
VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
VCEL stock results show that Vericel beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
March 11, 2024
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.
Via
Talk Markets
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.
Via
InvestorPlace
HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
January 16, 2024
Via
Benzinga
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
Via
Benzinga
Analyst Ratings for Vericel
October 16, 2023
Via
Benzinga
Analyst Ratings for Vericel
September 21, 2023
Via
Benzinga
Expert Ratings for Vericel
August 03, 2023
Via
Benzinga
Vericel: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
November 16, 2023
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.
Via
InvestorPlace
3 Strong Buy Stocks Set to Take Off in the Coming Months
November 10, 2023
These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in?
Via
InvestorPlace
Earnings Scheduled For November 8, 2023
November 08, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via
Benzinga
Vericel Earnings Perspective: Return On Capital Employed
February 28, 2023
Via
Benzinga
Analyst Expectations for Vericel's Future
February 27, 2023
Via
Benzinga
Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses
September 20, 2023
J Capital Research has released a short idea report on Vericel Corporation (NASDAQ:
Via
Benzinga
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
Analyst Ratings for Vericel
January 27, 2023
Via
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) may have had a successful year of novel drug development.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.